USPTO serial 79094022
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Durham DH1 3LP, GB
Durham DH1 3LP, GB
Durham DH1 3LP, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Sheridan Ross P.C.1560 Broadway, Suite 1200Denver, CO 80202UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in the induction of cell differentiation in cell cultures and synthetic small molecules for use in the induction of in-vitro cell differentiation, other than medical; cell growth media for growing cells for use in scientific research; media for cell culture for use, namely, in non-medical research and biotechnological laboratories; chemical preparations for biotechnological purposes, namely, for the induction of cell differentiation, in particular stem cell differentiation; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations, agents and reagents for use in cellular research; biochemicals, namely, monoclonal antibodies other than for medical or veterinary purposes; biochemicals, namely, antibodies for diagnostic, laboratory, industrial or scientific use other than medical; biochemical products containing antibodies for use in scientific research | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of skin and neuro-degenerative diseases; medical biological reagents for use in molecular biology; medical diagnostic reagents; medical diagnostic reagents for in vitro laboratory tests; chemical reagents for medical and veterinary purposes; chemical preparations, agents and reagents for medical and veterinary use, namely, in the differentiation of cell types; biological preparations for the treatment of skin and neuro-degenerative diseases; cell growth media for growing cells for medical or clinical use; diagnostic agents, preparations and substances for medical purposes, namely, for use in binding or detecting antibodies, and in the development of antibodies | SECTION 71 - CANCELLED | — |
| 009 | Cell culture apparatus and instruments for laboratory or research medical use; laboratory apparatus, namely, cell culture vessels, multiwell plates, petri dishes, cell culture well inserts, cell factories, cell culture flasks and bioreactors for use in the separation of antibodies; reaction units, namely, cell based assays, routine cell cultures, cell passaging and perfusion cell culture systems containing chemical or biological reagents; cell culture scaffolds, namely, microspun fibres and microporous polystyrene substrates coated with extra-cellular matrices; deep well plates, namely, deep reservoir petri dishes with and without well insert cradles used in laboratory research | SECTION 71 - CANCELLED | — |
| 040 | Batch biological and chemical treatment services of materials; batch biological and chemical material treatment involving cell culture processes and the differentiation of cell types; treatment of human, animal and plant cells, bacteria and antibody materials by culturing such cells in three dimensions; material treatment involving three dimensional cell culture processes and in-vitro stem cell differentiation | SECTION 71 - CANCELLED | — |
| 041 | Education services, namely, provision of training, arranging and conducting of seminars and workshops all in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; on-line non-downloadable electronic publications, namely, bulletins and journal articles in the fields of biology, biotechnology, cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy | SECTION 71 - CANCELLED | — |
| 042 | Scientific research and design services in the field of three dimensional cell culture and analytical processes; industrial analysis and research services in the field of cell culture, cell biology, toxicity and safety testing, tissue and disease modelling and drug efficacy; laboratory services, namely, analysis and research in the field of cell and tissue cultures and their treatment; biotechnology research; laboratory services relating to the production of antibodies; growing cell cultures for research purposes; testing pharmaceutical, medical and biological agents for others; consultancy relating to biotechnology | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Sep 25, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 30, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 22, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 22, 2019 | INPC | INVALIDATION PROCESSED | — |
| May 28, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 28, 2018 | C71T | CANCELLED SECTION 71 | — |
| Sep 29, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 21, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 22, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 5, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 4, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 21, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 6, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 6, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 16, 2011 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 28, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 28, 2011 | ALIE | ASSIGNED TO LIE | — |
| Sep 30, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 22, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 30, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 30, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 30, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 29, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 22, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 22, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |